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Abstract 
Although glucose is one of the most important physio-pathological substrates of aldose reductase, it 
is not an easy molecule for in vitro investigation into the enzyme. In many cases alternative aldoses 
have been used for kinetic characterization and inhibition studies. However these molecules do not 
completely match the structural features of glucose, thus possibly leading to results that are not fully 
applicable to glucose. We show how aldose reductase is able to act efficiently on L-idose, the C-5 
epimer of D-glucose. This is verified using both the bovine lens and the human recombinant 
enzymes. While the kcat values obtained are essentially identical to those measured for D-glucose, a 
significant decrease in KM was observed. This can be due to the significantly higher level of the free 
aldehyde form present in L-idose compared to D-glucose. We believe that L-idose is the best 
alternative to D-glucose in studies on aldose reductase. 
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INTRODUCTION 
The reduction of glucose catalyzed by aldose reductase (AR), which is the first and rate-limiting 
step of the polyol pathway, is considered as one of the main deleterious events leading to the onset 
of diabetic complications. In fact, the accumulation of sorbitol and the concomitant reduction in the 
antioxidant’s capability are significant factors leading to cell damage (for review see:[1,2]). In 
addition, AR efficiently intervenes in reducing hydrophobic aldehydes, such as 4-hydroxy-2-
nonenal and its Michael glutathionyl-adduct [3,4]). AR exerts a detoxifying action and at the same 
time triggers a cell signaling cascade related to the antioxidant defense. 
Despite being claimed as an in vivo substrate of AR, D-glucose is far from an ideal substrate for the 
enzyme. In fact, despite displaying a kcat comparable with other physiological and not physiological 
substrates [5-7], glucose is very poorly recognized by the enzyme with a measured KM ranging 
between 35 and 212 mM [5, 8-12]. Nevertheless, the poor kinetic performance of the enzyme acting 
on glucose does not compromise the postulated involvement of AR in the induction of long-term 
diabetic complications. This is because in hyperglycemic conditions, time is a factor that inexorably 
impacts on cell damage. 
Glyceraldehyde has been used in many instances as a model substrate for aldoses in in vitro studies 
on AR; however, due to the structural differences with glucose, it is advisable to go deep inside the 
enzyme kinetic properties using glucose itself as substrate. The kinetic data on glucose reduction 
are strongly affected by the hemiacetal structure of the sugar. The concentration of glucose free 
aldehyde, which is conceivably the form that is susceptible to the enzyme action, is very low. Its 
value at 25°C varies around 1.18 x 10
-3
 and 1.38 x 10
-3
 % of the total glucose concentration, as 
found from a CD/NMR approach and from urazole modification kinetic measurements, respectively 
[13]. This is mainly due to the special stability of the six membered hemiacetal ring structure of 
glucose, in which all the sterically significant substituents (i.e. the hydroxyl groups at C2, C3 and C4 
carbon atoms and the hydroxymethyl group at C6 carbon atom) can be simultaneously allocated in 
an equatorial position. 
The rather low level of the free aldehyde form has enabled researchers to speculate on the presumed 
extraordinary ability of AR to recognize glucose (i.e. its open form) as substrate [14,15]. This 
supported the idea of a multi-task nature of the active site of the enzyme, which is able to efficiently 
act on structurally different substrates, such as hydrophilic aldoses and hydrophobic aldehydes (i.e. 
alkanals or alkenals) [6]. In any event, the rather low level of the free aldehyde in glucose solutions 
creates complications for the kinetic characterization of the enzyme that acts on it. Thus, either a 
high concentration of the enzyme or enormous concentrations of glucose are required in order to 
have acceptable rate measurements. This may be critical when comparative inhibition studies are 
performed with different substrates [16]. 
L-idose is an aldo-hexose identical to D-glucose, except for the configuration at the C5 carbon atom. 
This appears to have a marked effect on the stability of the hemiacetal ring in which, in the most 
stable chair conformation, the three hydroxyl groups at C2, C3 and C4 are in an axial position and 
the hydroxymethyl group at C6 is in an equatorial position, or vice versa. The consequence is that 




%, according to CD/NMR 
or kinetic measurements, respectively) is present in solution at a level that is approximately 60 to 80 
fold higher than glucose [13]. Thus L-idose is structurally very similar to glucose, but with the 
advantage of exposing a concentration of the free aldehyde form that is much more suitable for 
enzyme activity measurements. 
We propose L-idose as a new suitable substrate for the measurement of AR activity, as it mimics 
glucose and confirms the multi-task nature of the AR site. 
 
Materials and Methods 
Materials 
L-idose came from Carbosynth. D,L-dithiothreitol (DTT), D,L-glyceraldehyde (GAL), D-glucose, 
Isopropyl β-D-1-thiogalactopyranoside (IPTG), NADPH, TRI® Reagent were from Sigma Aldrich. 
Reverse Transcriptase was from Invitrogen.  dNTP and Thermus aquaticus DNA polymerase were 
from GE-Healthcare. pGEM vector was from Promega. The expression vector pET30 was from 
Novagen. Plasmid MiniPrep Kit was from Euroclone. The QIAEX II Extraction kit was from 
Qiagen. All other chemicals were of reagent grade.  
 
Assay of aldose reductase. The activity of AR was determined at 37°C following the decrease in 




). The standard assay 
mixture contained 0.25 M sodium phosphate buffer pH 6.8, 0.18 mM NADPH, 2.4 M ammonium 
sulphate, 0.5 mM EDTA and 4.7 mM GAL. One unit of enzyme activity is the amount that 
catalyzes the conversion of 1 µmol of substrate/min in the above assay conditions. The above assay 
conditions were adopted also when D-glucose or L-idose were used as substrates instead of GAL. 
 
Expression of human recombinant aldose reductase. 
Total RNA was extracted from human placenta with TRI® Reagent, following the manufacturer’s 
protocol. cDNA was prepared from total RNA by reverse transcription, using 200 units of 
SuperScriptTM III Reverse Transcriptase and 0.5 µg of an oligo-dTprimer in a 50 µL total volume. 
The mixture also contained 0.5 mM of each dNTP, 75 mM KCl, 3 mM MgCl2, 10 mM DTT and 0.1 
mg/mL BSA in 50 mM Tris-HCl, pH 8.3. The reaction mixture was incubated at 50°C for 60 min 
and the product was directly used for PCR amplification or stored at -20°C. Aliquots of 1 L of 
crude cDNA were amplified in a Bio-Rad Gene CyclerTM thermocycler, using 2.5 units of 
Thermus aquaticus DNA polymerase, 1 mM of each dNTP, 1 M of each PCR primer, 50 mMKCl, 
2.5 mM MgCl2 and 0.1 mgmL
-1
BSA in 10 mM Tris-HCl, pH 8.3, containing 0.1% (v/v) Triton X-
100. At the 5’ end, we used the specific primer: 5'- CAT ATG GCA AGC CGT CTC CTG CTC 
AA-3', corresponding to the sequence encoding the first six amino acids of the mature protein and 
containing an Nde I restriction site for ligation into the expression vector, which at the same time 
provided the ATG codon for an additional methionine in position 1. At the 3’ end the specific 
primer: 5'- GAA TTC TCA AAA CTC TTC ATG GAA -3' encoded the last six amino acids, 
followed by a stop codon and an Eco RI restriction site.  
After an initial denaturation step at 95°C for 5 min, 35 amplification cycles were performed (1 min 
at 95°C, 30 sec at 50°C, 1 min at 72°C) followed by a final step of 7 min at 72°C. An amplification 
product of about 900 bp was obtained, in agreement with the expected size (948 bp). The crude 
PCR product was ligated into a pGEM vector without further purification, using a 1:5 
(plasmid:insert) molar ratio and incubating the mixture overnight, at room temperature. After 
transformation of E. coli XL-1 Blue competent cells with the ligation product, positive colonies 
were selected by PCR using the plasmid’s primers SP6 and T7 and grown in LB/ampicillin 
medium. DNA was extracted using the Plasmid MiniPrep Kit and custom sequenced at Eurofins 
MWG. pGEM plasmid containing the appropriate sequence was digested with Nde I and Eco RI 
restriction enzymes for two hours at 37°C and the digestion product was separated on agarose gel. 
The obtained fragment was purified from gel using QIAEX II Extraction kit and ligated into the 
expression vector pET30, previously linearized with the same enzymes. The resulting plasmid was 
sequenced and shown to encode the mature protein. 
For expression of recombinant protein, the pET-30 vector, containing the sequence encoding human 
aldose reductase, was used to transform BL21(DE3)pLysS E. coli cells. Protein expression was 
induced by adding IPTG to a final concentration of 0.4 mM when the culture had reached a value of 
O.D.600 = 0.8. Cells were grown overnight at 37°C, then harvested by centrifugation and sonicated. 
After centrifugation, the expressed protein was obtained in soluble form. The recombinant protein 
presented an additional methionine at the N-terminus as the sole modification with reference to the 
native enzyme. 
 
Purification of recombinant and bovine lens AR. Both the human recombinant (hAR) and the 
bovine lens AR (bAR) were purified following the same procedure [17]. The purity of both enzyme 
preparations was assessed by SDS-PAGE [18] and gels were stained with silver nitrate [19]. The 
specific activity of purified bAR and hAR was 1.2 and 5.3 U/mg, respectively. The purified bAR 
and hAR were stored at -80 °C in 10 mM sodium phosphate bufferpH 7.0 containing 2 mM DTT 
alone or in the presence of 30% (w/v) glycerol, respectively. Both enzymes were extensively 
dialyzed against 10 mM sodium phosphate buffer pH 7.0 before use.  
 
Other methods. Protein concentration was determined according to Bradford [20]. Statistical 




RESULTS AND DISCUSSION 
 
Glucose reduction through the polyol pathway is considered as the physio-pathological connection 
between hyperglycaemic conditions and the development of long-term diabetes complications, 
which explains the marked interest of the research community in characterizing AR and its 
susceptibility to inhibition. Since glucose has rather poor features as an AR substrate, it is not easily 
manageable as a substrate for kinetic studies. Glyceraldehyde is mostly commonly used as a 
hydrophilic substrate to study AR. However glyceraldehyde does not possess one of the main 
features of sugars with more than three carbon atoms, i.e. the potential to generate cyclic 
hemiacetals. Our data show that L-idose, which is a molecule structurally very closely related to D-
glucose, is a suitable substrate for measuring aldose reductase activity in kinetic as well as 
inhibition studies on the enzyme. 
The effectiveness of L-idose as a substrate for AR was tested on purified preparations of the bovine 
lens and on the human placental recombinant enzymes. The usefulness of L-idose as an AR 
substrate is clearly evident in Fig. 1, which reports the reaction rates measured at different 
concentrations of hAR using either L-idose or D-glucose as substrates. The sensitivity of the assay 
using L-idose led to reliable measurements at a rather low substrate concentration, in a wide range 
of enzyme levels. 
The reaction rates of bAR and hAR as a function of L-idose concentration are reported as double 
reciprocal plots in Figs. 2A and 2B, respectively. As a comparison, the same figures also show the 
rates of D-glucose reduction. The kinetic parameters deriving from these data are reported in 
Table1. Essentially the same kcat values were obtained for the transformation of the two aldoses 
catalyzed by bAR. In contrast, a decrease of approximately 90 fold was observed in the KM value, 
when L-idose was used as substrate rather than D-glucose. Similar considerations can be drawn for 
hAR. In fact, although the absolute values of kinetic parameters are different from those measured 
for bAR, there are essentially no differencesin the kcat values for the two aldoses. A decrease of 
approximately 50 fold was observed in the KM value when L-idose was used as a substrate instead 
of D-glucose. 
Thus the kcat values measured for hAR confirm that L-idose and D-glucose are transformed by the 
enzyme through an efficient and very similar catalytic event. The KM results could in principle be 
explained by the possible different abilities of both bAR and hAR to recognize the two substrates. 
However, the very similar structure of L-idose and D-glucose makes such an interpretation less 
feasible. A more useful explanation of the difference in KM  for the two substrates is the lower 
concentration of glucose free aldehyde compared to L-idose. In fact, on the assumption that the 
open chain of the substrate present at equilibrium is the only form interacting with the enzyme and 
using the relative concentration for both substrates that can be evaluated for the free aldehyde form 
in solution (approximately 1.28 x 10
-3
 % for D-glucose and 87.75 x 10
-3
 % for L-idose), calculated 
as the average between CD/NMR and urazole titration values [13], the emerging KM values for D-
glucose and for L-idose become much more similar than those obtained from nominal concentration 
values. For bAR, KM values for D-glucose and L-idose of 0.9 µM and 0.7 µM, respectively, were 
calculated. For hAR, KM values for D-glucose and L-idose of 2.6 µM and 3.5 µM, respectively, 
were calculated. Thus, the KM ratios for D-glucose and L-idose obtained when nominal substrate 
concentrations were used (Table 1) drop to approximately 1.3 and 0.7 for bAR and hAR, 
respectively, when the actual free aldehyde concentration is considered.  
 
The conclusion is that D-glucose and L-idose free aldehydes, as expected, behave similarly as AR 
substrates, displaying a high apparent affinity for the enzyme. Incidentally, the emergingKM values 
are even lower than those reported for aldoses free aldehydes (i.e. methylglyoxal or 
glyceraldehyde), for which KM values ranging between 5 and 42 µM have been reported [4,8,21-
23]. It is difficult at this point to comment on the absolute values of these derived KM for L-idose 
and D-glucose. In fact, the possible involvement of the hemiacetal structures in the kinetic process 
and a possible effect of the assay conditions on the level of the free aldehyde of both sugars could 
clearly affect the results. 
Concerning the susceptibility to inhibition, L-idose and D-glucose reduction appear to be inhibited 
in the same fashion by Sorbinil, a classical inhibitor of the enzyme. The double reciprocal plots 
analysis of the inhibition of the hAR-catalyzed reaction by Sorbinil, which acts through a 
uncompetitive type of inhibition [9,24,25], are reported in Fig.3. The secondary plots related to the 
two substrates show (Fig. 3, insets) comparable values of Ki (0,88 ± 0.18 S.E.M. and 0.75 ± 0.07 
S.E.M. µM for D-glucose and L-idose, respectively). 
In conclusion, our results indicate L-idose as an attractive alternative substrate to D-glucose for 
measuring AR activity. In fact, while the two molecules are very similar in terms of structural 
rearrangement, L-idose offers a much more suitable concentration of the free aldehyde form for 
activity measurements. Our data also confirm the ability of the enzyme to act efficiently on both 
highly hydrophilic as well as highly hydrophobic substrates, which is a key issue to be clarified for 
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Figure 1. Evaluation of aldose reductase activity using D-glucose or L-idose as substrate. 
The initial rate was evaluated at different hAR concentrations using the following concentrations of 
L-idose (closed symbols) and D-glucose (open symbols)as substrates: diamond, 2 mM; triangles, 4 
mM; circles, 10 mM. Error bars (when not visible are within the symbols size) represent the 
standard deviations of the mean from at least three independent measurements. 
 
 Figure 2. Double reciprocal plots for the reduction of D-glucose and L-idose catalyzed by 
aldose reductase. 
The initial rate measurements of the reduction of D-glucose (circles) and L-idose (triangles) are 
reported as double reciprocal plots. Panel A: The assays were performed in the presence of bAR at a 
final concentration of 20 mU/mL and 14 mU/mL for D-glucose and L-idose, respectively. Panel B: 
The assays were performed in the presence of  hAR at a final concentration of 53 mU/mL and 24 
mU/mL for D-glucose and L-idose, respectively. Error bars (when not visible are within the 
symbols size) represent the standard deviations of the mean from at least three independent 
measurements 
 Figure 3. Inhibitory effect of sorbinil on the reduction of D-glucose and L-idose 
The initial rate measurements of the reduction of D-glucose (Panel A) and L-idose (Panel B) 
catalyzed by hAR in the presence of Sorbinil are reported as Dixon plots. Insets in both panels refer 
to the secondary plots of the abscissa intercept values ± S.E.M. of Dixon plots (-x intercepts) as a 
function of substrate concentration. 
 
